A Phase 4 interventional study of Minocycline, Clindamycin, Tretinoin, Benzoyl Peroxide in Acne, sponsored by Medicis Global Service Corporation. Completed at 10 sites in United States. Open to participants aged 12 Years to 30 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2011-11-30.
Sponsored by Medicis Global Service Corporation · Phase 4, Interventional, and Treatment
To determine if a combination of three currently approved acne products are safe and effective for the treatment of moderate to severe acne
A Phase IV, Open-Label Study Evaluating the treatment for Combination Acne Therapy.
730 studies on the registry are indexed under Acne Vulgaris; 86 are open to participants now.
This study's enrollment of 97 is above the median of 69 across 628 interventional studies indexed under Acne Vulgaris.
Browse Acne Vulgaris studies →Medicis Global Service Corporation is the lead sponsor of 12 studies on the registry; none are open to participants now.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
Solodyn, Ziana, Triaz FC
Drug: Minocycline, Clindamycin, Tretinoin, Benzoyl Peroxide
Solodyn 1 tablet, Q day Ziana Gel, topical Q am Triaz FC, topical Q night
Proportion of patients showing improvement from Baseline and Week 12
Time frame: Week 12
This study is completed, as verified in Nov 2011. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Medicis Global Service Corporation